Pirlindole

This classification denotes a monoamine oxidase inhibitor with the molecular formula C15H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V39YPH45FZ, chemically known as 2,3,3a,4,5,6-hexahydro-8-methyl-1h-pyrazino(3,2,1-jk)carbazole but generally known as pirlindole, which bears US NIH Compound Identifier 68802. European Medicines Agency schedules Pirlindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09923MIG. The term PIRLINDOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). PIRLINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirlindole under HS 29335995 and SITC 51576. As of Q4 2014, PIRLINDOLE remains the US FDA Preferred Term for this commodity. Pirlindole bears US NLM identifiers UMLS ID C0071143 and NCI Concept Code C66428. SMILES: n12c3C(NCC1)CCCc3c1c2ccc(c1)C.